The cells that maintain your joints — the cartilage, the joint lining, even the pain nerves — carry oestrogen receptors ¹. For decades that hormone kept inflammation down and cartilage renewing. Around the last period the signal falls off, and the tissue that was buffered no longer is. The same pattern, same fingers and same morning stiffness, shows up in women on breast-cancer drugs that strip oestrogen on purpose: 20% to 74% develop joint pain within months of starting. Knock out the hormone deliberately, and the joints hurt.

The pain is real even when the scan is clean. Roughly 40% of women with these symptoms have a normal MRI: no torn cartilage, no swelling, nothing to point at ². That mismatch is why it gets missed. It peaks in the first years after the last period, then eases for most women over the following decade ². Hormone therapy helps modestly: in the largest trial, 76.3% on oestrogen reported joint pain versus 79.2% on placebo ³. Newer pooled data finds that effect hard to reproduce ⁴.

Resting the joint is the trap; the muscle around it is the fix. The first two steps are free.

The first thing that shifts is that you stop blaming yourself; knowing 70% of women your age share this lifts a layer of quiet shame off the morning ⁵. Within a few weeks of consistent strength work, the morning warm-up shrinks from forty minutes to ten. At three months, hormone responders lose the roll-over-at-night pain ³. The long arc is hands that still close in your seventies, a hip that gets you out of a chair without a hand.

Sharper cases: surgical menopause (ovaries removed early) hits harder and is the strongest indication for hormone therapy. On breast-cancer aromatase inhibitors, the joint pain is the same syndrome and a leading cause of stopping the drug — talk to your oncologist, don't quit alone. A single shoulder losing range may be frozen shoulder, also oestrogen-linked ⁶; see a specialist fast.